Decorative curls

Media

Follow along on our journey

Research Nova Scotia is investing $2.8M into clinical trials with far-UVC technology in senior homes. This is the only clinical trial of its kind in the world, and we’re very proud that UVX is the preferred far-UVC technology provider as the study enters its second phase. The trial will be led by Nova Scotia Health Authority, with world-renowned geriatrician Dr. Kenneth Rockwood serving as Principal Investigator.

UVX embarks on $2.8M project in Nova Scotia

Research Nova Scotia is investing $2.8M into clinical trials with far-UVC technology in senior homes. This is the only clinical trial of its kind in the world, and we’re very proud that UVX is the preferred far-UVC technology provider as the study enters its second phase. The trial will be led by Nova Scotia Health Authority, with world-renowned geriatrician Dr. Kenneth Rockwood serving as Principal Investigator.

August 23, 2023
https://www.vantechjournal.com/p/uvx-nova-scotia-trial
CBC News is Canada's largest news network. Their news article spotlights UVX's work with Nova Scotia Health Authority and Research Nova Scotia, discussing the technology's strong potential in reducing respiratory infection in seniors and other vulnerable populations.

UVX's work garners national coverage by CBC News

CBC News is Canada's largest news network. Their news article spotlights UVX's work with Nova Scotia Health Authority and Research Nova Scotia, discussing the technology's strong potential in reducing respiratory infection in seniors and other vulnerable populations.

August 10, 2023
https://www.cbc.ca/news/canada/nova-scotia/researcher-tests-uv-disinfection-long-term-care-homes-1.6931230
AGE-WELL is Canada’s technology and aging network for seniors, and SE Health is one of the largest players in the healthcare and senior care industries. Together, the two organizations have been looking for the most impactful technologies in senior care Canada-wide and UVX is honored to be the one they chose.

SE Health and AgeWell select UVX as Canada’s most impactful technology for senior care

AGE-WELL is Canada’s technology and aging network for seniors, and SE Health is one of the largest players in the healthcare and senior care industries. Together, the two organizations have been looking for the most impactful technologies in senior care Canada-wide and UVX is honored to be the one they chose.

June 22, 2023
https://www.newswire.ca/news-releases/enterprises-to-connect-families-and-protect-people-from-infection-win-national-impact-challenge-2023-bold-innovations-for-living-874335983.html
From UBC’s novel drug delivery system that enabled Pfizer/BioNTech SE and Moderna to create mRNA vaccines, to being the first university in the world to publish structural images of the Alpha variant spike protein at near-atomic resolution to assess antibody treatments, UVX is very honoured to be recognized amongst very important technologies spinning out of the UBC ecosystem.

UBC recognizes UVX as a major contributor to overcoming COVID-19 and reducing other infection risks moving forward

From UBC’s novel drug delivery system that enabled Pfizer/BioNTech SE and Moderna to create mRNA vaccines, to being the first university in the world to publish structural images of the Alpha variant spike protein at near-atomic resolution to assess antibody treatments, UVX is very honoured to be recognized amongst very important technologies spinning out of the UBC ecosystem.

March 13, 2023
https://magazine.alumni.ubc.ca/2023/health/combatting-covid-19-ubcs-contributions-overcoming-pandemic
UVX is pleased to be one of 25 companies to receive a total of $2.5M in funding from the Government of Canada via Sustainable Development Technology Canada (SDTC). SDTC helps promising startups accelerate the deployment of globally competitive clean technology solutions. We are so grateful to the Government of Canada for their continued support as UVX becomes the first Canadian manufacturer to commercialize Far-UVC technology for Canada and the world!

One of 25 companies to receive a total of $2.5M from Government of Canada

UVX is pleased to be one of 25 companies to receive a total of $2.5M in funding from the Government of Canada via Sustainable Development Technology Canada (SDTC). SDTC helps promising startups accelerate the deployment of globally competitive clean technology solutions. We are so grateful to the Government of Canada for their continued support as UVX becomes the first Canadian manufacturer to commercialize Far-UVC technology for Canada and the world!

January 17, 2023
https://www.sdtc.ca/en/sdtc-seed-funding-recipients-showcase-breadth-of-sustainable-innovation-across-canada/
UVX helps businesses reduce infection transmission risk through innovative light-based technology. The team has developed the world’s first intelligent ceiling device that continuously kills pathogens within seconds. Their technology disinfects both air and surfaces, even when people are present in the room.

UVX is one of 10 B.C. startups to watch in 2023

UVX helps businesses reduce infection transmission risk through innovative light-based technology. The team has developed the world’s first intelligent ceiling device that continuously kills pathogens within seconds. Their technology disinfects both air and surfaces, even when people are present in the room.

January 6, 2023
https://techcouver.com/2023/01/06/bc-startups-to-watch-in-2023/
UVX co-founders Saimir and Kunal helped install Zener devices at Louis Brier Home and Hospital, one of Canada's largest senior care facilities with 215 beds.

Installation at Louis Brier Home & Hospital, one of Canada's largest senior homes

UVX co-founders Saimir and Kunal helped install Zener devices at Louis Brier Home and Hospital, one of Canada's largest senior care facilities with 215 beds.

November 2, 2022
https://www.linkedin.com/feed/update/urn:li:activity:7003437789417521152
Canadian coast-to-coast, listeners learned about UVX on The Shift, a Global News radio segment and Canada’s most listened to night time radio. When the radio team reached out for their segment on UV technologies, we didn’t think the unpaid feature would result in overwhelming inbound interest, from cannabis growers to dental clinics to a hospital. Thank you for the feature, Handy Andy and Global News. Have a listen!

UVX is on Global News radio!

Canadian coast-to-coast, listeners learned about UVX on The Shift, a Global News radio segment and Canada’s most listened to night time radio. When the radio team reached out for their segment on UV technologies, we didn’t think the unpaid feature would result in overwhelming inbound interest, from cannabis growers to dental clinics to a hospital. Thank you for the feature, Handy Andy and Global News. Have a listen!

August 23, 2022
https://youtu.be/IHpLuYDg6s0
The TELUS venture investment arm (TELUS Pollinator Fund for Good) and Spring Activator organized a Canada-wide healthcare challenge. UVX was selected as Top 20 in February 2022, and then moved on to Top 10, and then ultimately to Top 5. A cohort of 35 investors then conducted due diligence on the Top 5 companies over 6-weeks, ultimately determining UVX to be Canada's most impactful and investable healthcare startup.

TELUS and Spring Activator determine UVX to be Canada's most impactful and investable healthcare venture

The TELUS venture investment arm (TELUS Pollinator Fund for Good) and Spring Activator organized a Canada-wide healthcare challenge. UVX was selected as Top 20 in February 2022, and then moved on to Top 10, and then ultimately to Top 5. A cohort of 35 investors then conducted due diligence on the Top 5 companies over 6-weeks, ultimately determining UVX to be Canada's most impactful and investable healthcare startup.

June 8, 2022
https://www.telus.com/en/blog/pollinatorfund/spring-activator-growth-of-impact-investors-health-startups
New Ventures BC is British Columbia’s largest (and most selective) industry-agnostic startup competition, with a panel of 95 judges from various industries. UVX was selected as a finalist for a chance to win $250,000 in cash and prizes.

UVX is a finalist in the New Ventures BC Competition

New Ventures BC is British Columbia’s largest (and most selective) industry-agnostic startup competition, with a panel of 95 judges from various industries. UVX was selected as a finalist for a chance to win $250,000 in cash and prizes.

June 6, 2022
https://www.newventuresbc.com/2022/09/ey-presents-the-2022-new-ventures-bc-top-11-finalists/
After months of evaluating amazing healthcare ventures, the TELUS venture investment arm (TELUS Pollinator Fund for Good) and Spring Activator select UVX as a Top 20 healthcare company Canada-wide.

TELUS and Spring Activator select UVX as Top 20 healthcare venture Canada-wide

After months of evaluating amazing healthcare ventures, the TELUS venture investment arm (TELUS Pollinator Fund for Good) and Spring Activator select UVX as a Top 20 healthcare company Canada-wide.

February 22, 2022
https://spring.is/programs/impact-investor-challenge/meet-the-top-20-startups-health-impact-investor-challenge/
UVX co-founders Saimir and Kunal demonstrated Zener, UVX's first product, at University of British Columbia's e@UBC Venture Showcase. In the category that UVX was presenting, UVX placed 2nd for People's Choice Award.

UVX demonstrates Zener at UBC's Venture Showcase and places 2nd in a category for People's Choice Award

UVX co-founders Saimir and Kunal demonstrated Zener, UVX's first product, at University of British Columbia's e@UBC Venture Showcase. In the category that UVX was presenting, UVX placed 2nd for People's Choice Award.

November 24, 2021
https://www.linkedin.com/feed/update/urn:li:activity:6869704931344023552/
UVX is excited to announce that the Division of Infectious Diseases, within the Faculty of Medicine at the University of British Columbia (UBC), has commenced testing of UVX’s core technology: filtered 222nm Far-UVC light produced by UVX’s flagship Zener device. The tests will be conducted at the Jack Bell Research Centre.

UBC’s Faculty of Medicine starts testing UVX’s human-safe ultra-violet technology

UVX is excited to announce that the Division of Infectious Diseases, within the Faculty of Medicine at the University of British Columbia (UBC), has commenced testing of UVX’s core technology: filtered 222nm Far-UVC light produced by UVX’s flagship Zener device. The tests will be conducted at the Jack Bell Research Centre.

September 1, 2021
The negative socio-economic effects of infectious diseases are undeniable. Yet traditional chemical disinfectants and UV solutions fail to effectively and efficiently mitigate these issues. Recognizing the shortcomings of traditional methods, UVX makes disinfection effortless, affordable, effective, sustainable, and safe for everyone.

UVX featured as "Startup of the Week", a highlight of British Columbia's most innovative and exiting startups

The negative socio-economic effects of infectious diseases are undeniable. Yet traditional chemical disinfectants and UV solutions fail to effectively and efficiently mitigate these issues. Recognizing the shortcomings of traditional methods, UVX makes disinfection effortless, affordable, effective, sustainable, and safe for everyone.

August 13, 2021
https://techcouver.com/2021/08/13/startup-of-the-week-uvx/
Engineer Kunal Sethi is secretive about what, exactly, his revolutionary germ-zapper will look like. But it will be small, he says: a programmable, ceiling-mounted device roughly the size of a Wi-Fi router that quietly bathes entire rooms in ultraviolet light — potentially saving tens of thousands of lives each year.

UVX Co-founder, Kunal, is recognized as a Changemaker by the University of British Columbia

Engineer Kunal Sethi is secretive about what, exactly, his revolutionary germ-zapper will look like. But it will be small, he says: a programmable, ceiling-mounted device roughly the size of a Wi-Fi router that quietly bathes entire rooms in ultraviolet light — potentially saving tens of thousands of lives each year.

June 23, 2021
https://trekmagazine.alumni.ubc.ca/2021/spring-2021/changemakers/health-technology/life-saving-light
Discover the Canadian healthtech start-ups to watch in 2021. MEDTEQ+, through its AIM coaching program, has selected about twenty promising companies in health technologies.

MEDTEQ+ names UVX as a Canadian healthtech startup to watch in 2021

Discover the Canadian healthtech start-ups to watch in 2021. MEDTEQ+, through its AIM coaching program, has selected about twenty promising companies in health technologies.

March 3, 2021
https://www.medteq.ca/en/canadian-healthtech-start-ups-to-watch-in-2021/?utm_source=linkedin&utm_medium=social&utm_campaign=AIM